InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by McKhann Chas, Chairman & CEO. Insider active across 2 companies, notably Apollo Endosurgery, Inc.. Cumulatively, 6 filings have been logged. Total volume traded: €594k. The latest transaction was filed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
0112,607 shares0
Common Stock
SEC:0001251769-22-000053:0·
€342,24566,553 shares@ €5.142436.6% of flow
Common Stock
SEC:0001251769-22-000036:0·
€148,41221,156 shares@ €7.015150.0% of flow
Common Stock
SEC:0001251769-21-000105·
€148,41221,156 shares@ €7.015150.0% of flow
Common Stock
SEC:0001251769-21-000107·
€148,41221,156 shares@ €7.015115.9% of flow
Common Stock
SEC:0001251769-21-000105:0·
€148,41221,156 shares@ €7.015115.9% of flow
Common Stock
SEC:0001251769-21-000107:0·
6 of 6 declarations
About McKhann Chas
Chas McKhann is the Chief Executive Officer of Apollo Endosurgery, Inc. He leads the company with a focus on innovation in the field of medical devices. His leadership is essential for the development and implementation of new health solutions.
